Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets

Nektar Therapeutics (Nasdaq: NKTR) will announce its third quarter 2022 financial results on November 3, 2022, following the close of U.S. financial markets.

Rhea-AI Summary

Nektar Therapeutics (Nasdaq: NKTR) will announce its third quarter 2022 financial results on November 3, 2022, following the close of U.S. financial markets. CEO Howard Robin will host a conference call at 5:00 p.m. ET to discuss the results. Investors can access the press release and live audio webcast on the Nektar website, with a replay available until December 3, 2022.

Nektar focuses on oncology, immunology, and inflammatory diseases, boasting a robust R&D pipeline.

Argus Session date unavailable

+2.17% session move Open Argus

Details

News Market Reaction – NKTR

The recorded move for NKTR in the trading session of this news was +2.17%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO, Oct. 25, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2022 on Thursday, November 3, 2022, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through December 3, 2022.

To access the conference call, please pre-register at Nektar Earnings Call Registration. All registrants will receive dial-in information and a PIN allowing them to access the live call.

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and inflammatory diseases as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contacts:

For Investors:                         
Vivian Wu of Nektar Therapeutics
628-895-0661

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-third-quarter-2022-on-thursday-november-3-2022-after-close-of-us-based-financial-markets-301659191.html

SOURCE Nektar Therapeutics

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Nektar Therapeutics announce its third quarter 2022 financial results?

Nektar Therapeutics will announce its third quarter 2022 financial results on November 3, 2022.

What time is the Nektar Therapeutics conference call for Q3 2022 results?

The conference call will take place at 5:00 p.m. Eastern Time on November 3, 2022.

How can I access Nektar Therapeutics' Q3 2022 financial results?

You can access the results and the live audio webcast on Nektar's website.

Is there a replay available for the Nektar conference call regarding Q3 2022 results?

Yes, the replay will be available until December 3, 2022.